Brentley Collins

FDA investigator

Appears on 11 documents from 2019 to 2024, most often at sites in Massachusetts. Most often cites production record review (21 CFR 211.192).

11
Documents on file
3.7
Observations per 483
2019
First seen
2024
Most recent

What they cite most

From 41 observations

Activity by year

2019: 1, 2021: 3, 2022: 1, 2023: 3, 2024: 3

Where

Massachusetts 2 · Michigan 2 · Georgia 1 · Illinois 1 · Indiana 1 · North Carolina 1

Is Brentley Collins coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Sharp Sterile Manufacturing, LLCJun 12, 2024 · Lee, Massachusetts
483 Afton Scientific, LLCMay 8, 2024 · Charlottesville, Virginia
483 MedImmune UK LimitedMar 15, 2024 · Liverpool, United Kingdom
483 Emergent Biodefense Operations Lansing LLCDec 13, 2023 · Lansing, Michigan
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCSep 19, 2023 · Andover, Massachusetts
483 CSL Behring L.L.C.Mar 2, 2023 · Bradley, Illinois
483 Dendreon Pharmaceuticals LLCApr 21, 2022 · Union City, Georgia

About this profile

What does Brentley Collins inspect?

Brentley Collins appears on 11 documents on file covering 10 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Brentley Collins is dated Jun 12, 2024.